Patrick Olaniyi

Urology registrar. Academic research. Special interest in molecular biology, diagnostic tests, improving patient safety.

[Joe Philip 🇬🇧🇮🇳 @JoeUrol]

For Urologists Opinion: In an acute scrotal exploration, where no torsion is identified, do you…..?@Patrick47872001 @leeurol @BURSTurology @IPearce82 @PatrickUrology @jake_p76 @stingrai78 @UroZedman @AndrolAyo @endouro @EndoLuminalEndo @ferasjaafari @lithohlr @vishhanchanale

[Mehwash Nadeem @Mehwash_Nadeem]

My favourite slide from #Nigel Parr's presentation:
Treat your trainees as you would wish your children to be treated @IBUSurology @BAUSurology @joeurol @BSoT_UK #BAUS22

[Eur Urol Focus @EurUrolFocus]

Current Issue: Qualitative Assessment of the Conservative Management of Nocturia with Standardised Written Materials for Lower Urinary Tract Symptoms in Men Treated in Primary Care

https://t.co/zlTSJ0nNII

@Patrick47872001 @NikkiC07 @MarcusDrakeUrol

#urology #medtwitter

[Marcus Drake @MarcusDrakeUrol]

Some important lessons, including not to downplay urinary symptoms as part of getting older. Free access to the article via this link if downloaded before 4th March 2022 https://t.co/7ZCVKNL4V8

[European Association of Urology (EAU) @Uroweb]

Prostate cancer is now the most commonly diagnosed cancer in England, overtaking breast cancer for the first time.

#prostatecancer

https://t.co/JAH9r2p2hY

[UCARE @UCAREoxford]

With your help, these are some of the researchers working on cancer we have supported in the last few years. https://t.co/xXwJzN7RQo

[Oxford Cancer @OxfordCancer]

Training the next generation of clinician scientists starts today at the CRUK Oxford Centre Clinical DPhil Open Day. Find out more here & on our website for details/timelines on how to apply for our @cruk funded positions.
https://t.co/kWTuyXRVdO
@CRUKresearch @OxfordMedSci

[Bryant_Lab @LabBryant]

Increased EZH2 expression in prostate cancer is associated with metastatic recurrence following external beam radiotherapy.
Thankyou ⁦@UCAREoxford⁩ and ⁦@CR_UK⁩ for support
⁦@The_OIRO⁩
⁦⁦@NDSurgicalSci⁩ ⁦@SigridCarlsson⁩ https://t.co/sa52lS2L1Z

[European Urology @EUplatinum]

A phase II study finds better quality of life for abiraterone vs enzalutamide in men ≥ 75 years with #prostatecancer https://t.co/2O5UC8RHhG

[Hein Van Poppel @heinvanpoppel]

We can not allow that Prostate cancer continues to kill thousands of men, and that the PCa mortality is now even increasing since the introduction of arguments against PSA screening.

[Professor Henry Woo @DrHWoo]

Exhausted surgeon dismissed as an 'emotional female'
This appalling treatment of unaccredited registrars is an unconscionable act of exploitation. Surgeons 'supervising' this trainee do not deserve to be in the role as trainers. https://t.co/Taeq5zyg7Z via @smh @kaubo